Zydus Executive and Leadership Team

Rishikesh Raval, the Group President, Human Resources & Corporate Communications at Zydus, directs the organizational development and internal messaging strategies across all global manufacturing sites. Overseeing talent acquisition and employee engagement, the Group President, Human Resources & Corporate Communications ensures alignment between workforce capabilities and the company's pharmaceutical production goals. This leadership role involves managing complex communication frameworks that support Zydus in maintaining a cohesive corporate culture across diverse international regions. By optimizing human capital management, Rishikesh Raval directly impacts the operational efficiency of research facilities. Furthermore, Raval implements robust training programs that elevate technical expertise within the workforce. Through these initiatives, the Group President, Human Resources & Corporate Communications secures the long-term stability of the company's human infrastructure, fostering an environment conducive to high-level pharmaceutical innovation and sustained growth in competitive global markets.

Mangesh Vaze, the President, Api Business at Zydus, manages the end-to-end production and distribution of active pharmaceutical ingredients. Overseeing supply chain logistics and manufacturing quality, the President, Api Business ensures that all chemical components meet rigorous international regulatory standards. This leadership role involves coordinating with research teams to scale production for emerging markets while maintaining a strong presence in the United States and Brazil. By streamlining manufacturing processes, Mangesh Vaze directly impacts the availability of essential pharmaceutical products. Furthermore, Vaze drives cost-efficiency initiatives that enhance the competitive positioning of the company's ingredient portfolio. Through strategic oversight of production facilities, the President, Api Business secures the reliability of the supply chain, ensuring that Zydus maintains its reputation for quality and consistency in the global pharmaceutical landscape while meeting the complex demands of diverse healthcare sectors.

Harish Sadana, the President Corporate Matters at Zydus, governs the legal and regulatory frameworks that define the company's global operations. Overseeing compliance and corporate governance, the President Corporate Matters ensures that all business activities align with international pharmaceutical standards across Europe, South Africa, and Latin America. This leadership role involves managing high-level interactions with regulatory bodies to facilitate market entry and product distribution. By mitigating legal risks, Harish Sadana directly impacts the company's ability to expand its footprint in regulated markets. Furthermore, Sadana architects internal policies that promote ethical business practices throughout the organization. Through these efforts, the President Corporate Matters secures the integrity of the company's operations, providing a stable foundation for the development and distribution of pharmaceutical products while navigating the intricate legal landscapes inherent in the global healthcare industry.

Kacharu Toshniwal, the President at Zydus, oversees the broad operational execution of pharmaceutical manufacturing and distribution strategies. Managing cross-functional teams, the President ensures that production targets align with the company's overarching mission to provide accessible healthcare solutions. This leadership role involves coordinating with various departments to optimize resource allocation across manufacturing sites in India and abroad. By driving operational excellence, Kacharu Toshniwal directly impacts the company's ability to meet the needs of diverse global markets. Furthermore, Toshniwal monitors performance metrics to ensure that all business units maintain high standards of quality and efficiency. Through these strategic efforts, the President secures the company's market position, fostering a culture of continuous improvement and operational agility that supports the development and delivery of a comprehensive portfolio of pharmaceutical products to patients worldwide.

Kapil Maithal, the President, Vaccines and Diagnostics at Zydus, directs the research, development, and commercialization of specialized medical products. Overseeing clinical trials and diagnostic innovation, the President, Vaccines and Diagnostics ensures that new offerings meet the urgent health needs of global populations. This leadership role involves collaborating with research facilities to accelerate the transition from laboratory discovery to market-ready solutions. By advancing the company's vaccine portfolio, Kapil Maithal directly impacts the public health outcomes in both emerging and regulated markets. Furthermore, Maithal manages the integration of diagnostic technologies into the broader pharmaceutical service model. Through these initiatives, the President, Vaccines and Diagnostics secures the company's role as a leader in medical innovation, driving growth through the development of high-impact products that address critical healthcare challenges while maintaining the highest standards of safety and efficacy.

Nitinkumar Parekh, the President (Special Projects) at Zydus, leads high-priority initiatives that drive long-term strategic growth and operational transformation. Overseeing the implementation of complex business projects, the President (Special Projects) ensures that unique opportunities for market expansion are fully realized. This leadership role involves analyzing emerging trends to identify potential areas for investment and development within the pharmaceutical sector. By spearheading these initiatives, Nitinkumar Parekh directly impacts the company's ability to adapt to changing global healthcare demands. Furthermore, Parekh coordinates with other C-suite leaders to align special projects with the company's core mission and financial objectives. Through these efforts, the President (Special Projects) secures the company's future competitiveness, fostering innovation and agility that allow Zydus to maintain its status as a global leader in the pharmaceutical industry while exploring new frontiers in medical technology and service delivery.

Dr.Amrut Naik, the President at Zydus, leads the scientific research and development efforts that underpin the company's pharmaceutical portfolio. Overseeing laboratory operations and clinical research, the President ensures that all scientific endeavors align with the company's commitment to medical excellence. This leadership role involves guiding research teams in the discovery of new therapeutic agents and the refinement of existing products. By fostering a culture of scientific rigor, Dr.Amrut Naik directly impacts the quality and efficacy of the company's pharmaceutical offerings. Furthermore, Naik collaborates with other executives to translate research breakthroughs into viable market products. Through these strategic efforts, the President secures the company's reputation for innovation, ensuring that Zydus remains at the forefront of pharmaceutical science while addressing the evolving health needs of patients across diverse global markets through advanced research and development capabilities.